| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2013 | CN103446194A Anti-cancer oral medicine prepared from Chinese yew extract |
| 12/18/2013 | CN103446192A Soft capsule for inhibiting canceration |
| 12/18/2013 | CN103446181A Preparation process of peritoneal dialysate with physiologic pH value |
| 12/18/2013 | CN103446180A Bacterial cellulose-chitosan plural gel as well as preparation method thereof and application thereof in intracorporal treatment |
| 12/18/2013 | CN103446179A Application of amphiphilic poly-fullerene tree-based cross-linked poly-cation gel as chelating agent for binding phosphate, fatty acid and bile acid |
| 12/18/2013 | CN103446178A Application of lauromacrogol in preparation of medicine for treating pyogenic granuloma |
| 12/18/2013 | CN103446177A Cleansing solution for curing gynecological disease and preparation method thereof |
| 12/18/2013 | CN103446176A Chlorhexidine and oligochitosan-containing pharmaceutical composition and applications thereof |
| 12/18/2013 | CN103446175A Applications of water-soluble amino sugar in preparation of medicaments and health-care products for treating hyperuricemia, gout and nephropathy |
| 12/18/2013 | CN103446174A Application of mannuronic acid oligomers in preparing medicines, health products or dietary supplements for preventing and treating alcoholic liver injury |
| 12/18/2013 | CN103446173A Poultry solution capable of boosting intestinal tract and improving resistance and preparation method thereof |
| 12/18/2013 | CN103446172A Application of fructus camptothecae acuminatae extractive vincoside lactam |
| 12/18/2013 | CN103446171A Composition for treating swine respiratory tract infection and preparation method thereof |
| 12/18/2013 | CN103446170A SGLT2 (Sodium-glucose co-transporter 2) inhibitor and use thereof |
| 12/18/2013 | CN103446169A New use of notoginsenoside R1 |
| 12/18/2013 | CN103446168A Protection and action mechanisms of combination of gastrodin and rhynchophylla to vascular endothelial cells |
| 12/18/2013 | CN103446167A Application of salidroside in preparation of medicine for treating stroke |
| 12/18/2013 | CN103446166A Liver function-improving agent |
| 12/18/2013 | CN103446165A Application of guluronic acid oligomers in preparing medicines, health products or dietary supplements for preventing and treating alcoholic liver injury |
| 12/18/2013 | CN103446164A Compound sulfamonomethoxine sodium injection and preparation method thereof |
| 12/18/2013 | CN103446163A Compound preparation aspirin and caffeine tablet low in content of free salicylic acid and preparation method thereof |
| 12/18/2013 | CN103446162A Applications of 3 beta, 20(s), 21-trihydroxydammarane-24-alkene on preparation of tumor multi-drug resistance (MDR) reversing agents |
| 12/18/2013 | CN103446161A Compound galanthamine preparation |
| 12/18/2013 | CN103446160A Pharmaceutical composition containing cefoperazone sodium for injection and lidocaine hydrochloride injection |
| 12/18/2013 | CN103446159A Pharmaceutical composition containing pediatric compound amino acid injection and cefotiam hydrochloride |
| 12/18/2013 | CN103446158A Pharmaceutical composition of cefmenoxime hydrochloride and pediatric compound amino acid injection |
| 12/18/2013 | CN103446157A Compound amino acid-vitamin capsule and preparation method thereof |
| 12/18/2013 | CN103446156A Application of caffeine in preparing anticoagulation medicine |
| 12/18/2013 | CN103446155A mTOR (Mammalian Target Of Rapamycin) inhibitor and use thereof |
| 12/18/2013 | CN103446154A Applications of coumarin derivatives in preventing and curing serious brain diseases |
| 12/18/2013 | CN103446153A Composition and soft capsule for treating cold for night use |
| 12/18/2013 | CN103446152A Application of Lycojaponicumin C in anti-Helicobacter pylori drug |
| 12/18/2013 | CN103446151A Application of Lycojaponicumin C in drug for treating dengue virus infection |
| 12/18/2013 | CN103446150A Application of Lycojaponicumin C in liver cancer treatment drug |
| 12/18/2013 | CN103446149A Application of Lycojaponicumin C in small intestine peristalsis promoting drug |
| 12/18/2013 | CN103446148A Application of Lycojaponicumin C in anti-influenza A virus drug |
| 12/18/2013 | CN103446147A Application of Lycojaponicumin C in cervical cancer treatment drug |
| 12/18/2013 | CN103446146A Application of Lycojaponicumin C in ileocecum cancer treatment drug |
| 12/18/2013 | CN103446145A Application of Lycojaponicumin C in anti-tubercle bacillus drug |
| 12/18/2013 | CN103446144A Application of Lycojaponicumin C in biliary duct cancer treatment drug |
| 12/18/2013 | CN103446143A Application of Lycojaponicumin C in gastric cancer treatment drug |
| 12/18/2013 | CN103446142A Application of Lycojaponicumin C in pancreatic cancer treatment drug |
| 12/18/2013 | CN103446141A Application of Lycojaponicumin C in tongue cancer treatment drug |
| 12/18/2013 | CN103446140A Application of rhynchophylline in preparation of drug with anxiolytic effect and antidepressant effect |
| 12/18/2013 | CN103446139A Medicine composition for treating metabolic syndrome |
| 12/18/2013 | CN103446138A Neuroendocrine tumor treatment using mtor inhibitors |
| 12/18/2013 | CN103446137A Application of Lycojaponicumin A in drug for treating yellow fever virus infection |
| 12/18/2013 | CN103446136A Application of Lycojaponicumin A in anti-lung cancer metastasis drug |
| 12/18/2013 | CN103446135A Application of Lycojaponicumin A in anti-human fungus drug |
| 12/18/2013 | CN103446134A Application of Lycojaponicumin A in leukemia treatment drug |
| 12/18/2013 | CN103446133A Application of Lycojaponicumin B in tongue cancer treatment drug |
| 12/18/2013 | CN103446132A Application of Lycojaponicumin A in liver fibroblast proliferation inhibiting drug |
| 12/18/2013 | CN103446131A Application of Lycojaponicumin B in liver fibroblast proliferation inhibiting drug |
| 12/18/2013 | CN103446130A Application of Lycojaponicumin B in liver cancer treatment drug |
| 12/18/2013 | CN103446129A Application of Lycojaponicumin A in anti-tubercle bacillus drug |
| 12/18/2013 | CN103446128A Application of Lycojaponicumin B in skin cancer treatment drug |
| 12/18/2013 | CN103446127A Application of Lycojaponicumin A in anti-Helicobacter pylori drug |
| 12/18/2013 | CN103446126A Application of Lycojaponicumin B in anti-herpes virus drug |
| 12/18/2013 | CN103446125A Application of Lycojaponicumin B in antibacterial drug |
| 12/18/2013 | CN103446124A Application of Lycojaponicumin B in small intestine peristalsis promoting drug |
| 12/18/2013 | CN103446123A Application of Lycojaponicumin B in colorectal cancer treatment drug |
| 12/18/2013 | CN103446122A Application of Lycojaponicumin B in prostate cancer treatment drug |
| 12/18/2013 | CN103446121A Application of Fluevirosines A in preparation of antidepressant drug |
| 12/18/2013 | CN103446120A Application of Fluevirosines A in preparation of anti-platelet aggregation drug |
| 12/18/2013 | CN103446119A Application of Fluevirosines A in preparation of acute renal failure treating drug |
| 12/18/2013 | CN103446118A Application of Sarcaboside A in drug for treating hemorrhagic fever with renal syndrome |
| 12/18/2013 | CN103446117A Applications of Sarcaboside A in medicament against helicobacter pylori |
| 12/18/2013 | CN103446116A Applications of Sarcaboside B in medicament against herpes virus |
| 12/18/2013 | CN103446115A Applications of Sarcaboside A in medicament against human fungus |
| 12/18/2013 | CN103446114A Applications of Sarcaboside A in antibacterial medicament |
| 12/18/2013 | CN103446113A Applications of Sarcaboside B in medicament for treating dengue virus infection |
| 12/18/2013 | CN103446112A Applications of Sarcaboside A in medicament against influenza A virus |
| 12/18/2013 | CN103446111A Applications of Sarcaboside B in medicament against influenza A virus |
| 12/18/2013 | CN103446110A Applications of Sarcaboside A in medicament against herpes virus |
| 12/18/2013 | CN103446109A Applications of Sarcaboside B in medicament against mycobacterium tuberculosis |
| 12/18/2013 | CN103446108A Applications of Sarcaboside B in medicament for treating hemorrhage fever with renal syndrome |
| 12/18/2013 | CN103446107A Applications of Sarcaboside A in medicament against mycobacterium tuberculosis |
| 12/18/2013 | CN103446106A Applications of Sarcaboside B in antibacterial medicament |
| 12/18/2013 | CN103446105A Applications of Sarcaboside A in medicament for treating yellow fever virus infection |
| 12/18/2013 | CN103446104A Applications of Sarcaboside B in medicament against helicobacter pylori |
| 12/18/2013 | CN103446103A Applications of Sarcaboside B in medicament against respiratory syncytial virus |
| 12/18/2013 | CN103446102A Applications of Sarcaboside B in medicament against yellow fever virus infection |
| 12/18/2013 | CN103446101A Application of Chukrasone B in medicament for treating liver cancer |
| 12/18/2013 | CN103446100A Arctigenin sublingual preparation |
| 12/18/2013 | CN103446099A Applications of icaritin in preparing medicament for preventing and treating alzheimer disease |
| 12/18/2013 | CN103446098A Flavonoid compound in traditional Chinese medicine radix scutellariae serving as DXR inhibitor |
| 12/18/2013 | CN103446097A Application of Incarviatone A in small intestinal peristalsis promoting drug |
| 12/18/2013 | CN103446096A Application of Incarviatone A in monoamine oxidase inhibitor drug |
| 12/18/2013 | CN103446095A Application of Incarviatone A in anti-human fungus drug |
| 12/18/2013 | CN103446094A Application of Incarviatone A in anti-respiratory syncytial virus drug |
| 12/18/2013 | CN103446093A Application of Incarviatone A in drug for treating hemorrhagic fever with renal syndrome |
| 12/18/2013 | CN103446092A Application of Incarviatone A in cervical cancer treatment drug |
| 12/18/2013 | CN103446091A Application of Incarviatone A in laryngeal cancer treatment drug |
| 12/18/2013 | CN103446090A Application of Incarviatone A in liver fibroblast proliferation inhibiting drug |
| 12/18/2013 | CN103446089A Application of Incarviatone A in nasopharynx cancer treatment drug |
| 12/18/2013 | CN103446088A Application of Incarviatone A in skin cancer treatment drug |
| 12/18/2013 | CN103446087A Application of Incarviatone A in endometrial cancer treatment drug |
| 12/18/2013 | CN103446086A Application of Incarviatone A in gastric cancer treatment drug |
| 12/18/2013 | CN103446085A Application of Incarviatone A in anti-Helicobacterpylori drug |
| 12/18/2013 | CN103446084A Application of Incarviatone A in pancreatic cancer treatment drug |